REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

REPRODIVAC group in Lyon

REPRODIVAC Annual Meeting at École normale supérieure de Lyon

The third REPRODIVAC annual meeting this year was held on 27 and 28 of August 2025 at École normale supérieure de Lyon, France.

reprodivac

UMU at 27th NATIONAL SHEEP FORUM

From 16 to 18 of  June 2025, members of the UMU team,  the researchers Jesus Salinas and Maria Rosa Caro, participated in the 27th NATIONAL SHEEP FORUM in Valladolid (Spain).

Twelfth thematic card

The twelfth thematic card about Qfever (Coxiellosis) has been published

A new thematic card is now available to learn more about 'Q fever', a disease caused by the bacterium Coxiella burnetii, the available commercial vaccine and the solutions of the REPRODIVAC project.

Laura del Rio presenting REPRODIVAC

Reprodivac disseminated at Continuing Professional Development (CPD) initiative, promoted by HIPRA

Reprodivac scientist Laura del Río from UMU has participated as a lecturer in a series of seminars held in various cities across Spain. These sessions were focused on veterinary practitioners working with small ruminants, providing an excellent opportunity to address key challenges in disease prevention—particularly the complex issue of enzootic abortion caused by Chlamydia abortus.

Nerea Lopez presentation

REPRODIVAC Presentation at the XXX SEM Congress: Doctoral Research Spotlight

The REPRODIVAC project was proudly presented at the XXX Congress of the Spanish Society for Microbiology (SEM), held recently in Jaén, Spain. This national scientific event brought together leading researchers in Microbiology from across Spain to share advances, foster collaboration, and highlight emerging talent in the field.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

Feedback